Comfrey and back pain

What 3 graded rows on comfrey agree on for back pain, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Comfrey page, with its PubMed record.

Your question

Comfrey and back pain

3 rows · 714 people

They agree: all 3 rows found an improvement.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade B× 2
  • Grade C× 1
Rows
3
Trials
3
People
714

What the rows share

From the rows

The best-graded row, grade B, is a randomized trial of 379 people (2013) and found an improvement.

The rows run from 120 to 379 people, published from 2005 to 2013: 3 single studies.

The rows

3 improved
  1. Grade BAcute back pain: comfrey plus methyl nicotinate vs methyl nicotinate alone · Improved

    RCT · n 379 · 2013 · Adults with acute upper or low back pain in a multicentre, three-arm trial

    A 12 cm layer three times a day · 5 days

    Pain on movement (area under the curve) was markedly smaller with the combination than with methyl nicotinate alone or placebo (p < 0.0001); methyl nicotinate alone also had a considerable effect.

    Row on the Comfrey page · PubMed 22887778 (opens PubMed)

  2. Grade BAcute upper or lower back pain (vs placebo) · Improved

    RCT · n 120 · 2010 · Adults with acute upper or lower back pain (mean age 36.9)

    4 g three times a day · 5 days

    Pain intensity on standardised movement fell by a median of about 95.2% with comfrey vs 37.8% with placebo, a significant difference that was consistent across all secondary measures; an effect was seen within 1 hour.

    Row on the Comfrey page · PubMed 19460762 (opens PubMed)

  3. Grade CMuscle pain in the back: 10% vs 1% herb cream · Improved

    RCT · n 215 · 2005 · Patients with myalgia in the lower and upper back

    Topical cream as directed in the trial · Not stated in the abstract

    Pain on movement, at rest and on palpation improved significantly more with the 10% cream; the number needed to treat was 3.2 and onset was faster. Tolerability was good to excellent.

    Row on the Comfrey page · PubMed 16510384 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.